You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股消息》3D MEDICINES-B(01244.HK)公開發售超購近5倍及定價24.98元 一手中籤率約25%
阿思達克 12-14 08:24
生物醫藥公司3D MEDICINES-B(01244.HK)公布招股結果,每股發售價定為24.98元,為招股價範圍(22.96至26.24元)的接近中間價定價。香港公開發售部分錄得超額認購約4.97倍。每手500股計,一手中籤率為25.01%,認購七手即3,500股穩獲一手。該股將於明日(15日)掛牌。聯席保薦人為中金及中信建投國際。 公司上市引入4名基石投資者,包括徐州經開區(香港)、Harvest、TradArt Investment SP及Mobilewise,合共認購939.15萬股公司股份,佔公司股本總額約3.67%。 公司上市料淨集約2.51億元,當中約90%擬用於產品和候選藥物的研發、監管備案及商業化;約10%用於一般企業及營運資金用途。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account